The Encyclopedia of Peptides

A to Z / Approved medicine

Desmopressin

Also known as DDAVP, Minirin, vasopressin analogue.

Best known for The vasopressin analogue for diabetes insipidus and bedwetting
Evidence★★★★★
Safety dataWell characterised
Route oral tablet, sublingual wafer, nasal spray or injection
United StatesFDA approved
AustraliaSchedule 4: prescription only
as at 16 September 2026

What it is and what it does

Desmopressin is a synthetic analogue of vasopressin, modified to act on water retention without raising blood pressure. It is a long-established approved medicine. It is used to reduce excessive urine production in diabetes insipidus and night-time bedwetting, and in some bleeding disorders.

What the full entry covers

The book carries the rest of this entry:

Related entries

A certificate of analysis tells you what is in a vial. The evidence rating above tells you whether the compound has been shown to work in humans. Neither answers the other's question. How to read a certificate of analysis.

This page describes what is known and not known about Desmopressin. It is not medical advice and not a recommendation to use it.